TTX
TTRATHERIX FPO [TTX]
Healthcare · ASX Small Cap
$4.6800 -0.6%
Updated 26 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +12First seen: 2026-03-16
Score Breakdown
Technical56
Catalyst51
Sentiment50
Fundamental85
Momentum75
Risk Gate50
Get alerts when TTX's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Beating the Small Ords index — relative strength of 1.31, so it's outpacing the pack
- Strong cash runway (13 quarters)
- Very high P/S ratio (118.9x)
- Strong revenue growth (+206%)
- EPS estimates revised upward (+10pts)
- CANSLIM S: Tight float (20%)
- Sentiment is mixed — no strong consensus either way
- Positive long-term momentum — up 31% over the past year
- Revenue growing at +206% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (1.90%/day)
- RBA hiking (-3pts)
- Overseas risk_off (-3pts, S&P500 strong_down, VIX 25)
Risk Signals
- Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about TTX
3 free messages/day · Unlimited with Pro
Recent Catalysts
LOW Tetratherix March Investor Presentation
NONE Precision medicine franchise launch and new revenue
NONE Tutelix Update
NONE HY FY26 Letter
Recent ASX Announcements
| 2026-03-16 | Tetratherix March Investor Presentation |
| 2026-03-15 | Precision medicine franchise launch and new revenue PRICE SENSITIVE |
| 2026-03-09 | Tutelix Update PRICE SENSITIVE |
| 2026-02-24 | HY FY26 Letter |
| 2026-02-23 | Half Yearly Report and Accounts PRICE SENSITIVE |
Key Metrics
$237.6M
Market Cap
17K
Avg Volume
1.4x
Vol Ratio
$2.88 — $5.80
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-150.0%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 20% |
| L | Leader vs Laggard | pass | RS: 9 |
| I | Institutional Sponsorship | weak | Inst: 2% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #42 of 117 · Sector avg: 45
View all Healthcare signals →Track TTX and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required